Evaluation of the effect of supervised anti-malarial treatment on recurrences of Plasmodium vivax malaria

Abstract Background Relapses in vivax malaria have posed great challenges for malaria control, and they also account for a great proportion of reported cases. Knowing the real effectiveness of a 7-day primaquine (PQ) scheme is crucial in order to evaluate not only the cost-effectiveness of implement...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Kelry Mazurega Oliveira Dinelly, Sheila Vitor-Silva, Jose Diego Brito-Sousa, Vanderson Souza Sampaio, Milena Gabriela Oliveira Silva, André Machado Siqueira, Cássio Peterka, Sheila Rodovalho, Aretha Gomes Omena, Wuelton Marcelo Monteiro, Marcus Vinícius Guimarães Lacerda, Gisely Cardoso Melo
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2021
Subjects:
Malaria
Plasmodium vivax
Supervised treatment
Unsupervised treatment
Recurrence
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Arctic
Online Access:https://doi.org/10.1186/s12936-021-03793-0
https://doaj.org/article/6bc37f34e7d446d789dcc52cce7acab3
Description
Summary:Abstract Background Relapses in vivax malaria have posed great challenges for malaria control, and they also account for a great proportion of reported cases. Knowing the real effectiveness of a 7-day primaquine (PQ) scheme is crucial in order to evaluate not only the cost-effectiveness of implementing new anti-hypnozoite drugs, but also how health education strategies can guarantee better compliance and be reinforced. This study aimed to evaluate the effect of daily treatment with chloroquine and PQ supervised by health workers versus prescription without supervision. Methods The outcome was the passive detection of new positive thick blood smears up to 180 days, based on the official data records from the National Malaria Control Programme. The recurrences seen in the real life were, therefore, used as a surrogate for true relapses. Results Patients under supervised treatment had a lower risk of recurrence up to day 180 when compared to the unsupervised treatment (17.9% vs. 36.1%; p = 0.027). Conclusions The lack of supervision in the non-supervised group (which followed standard of care in the real life) enabled proper comparison, as consent itself would have lead to greater compliance in this group. Future studies should scale such an analysis to different settings in the Brazilian Amazon.

Similar Items